• Moderna climbs as 4th-quarter sales blow past expectations and 2021 forecasts surge

    1 month ago - By Business Insider

    Summary List Placement Shares of Moderna soared as high as 10% on Thursday after the biotech company revealed fourth-quarter sales that were more than double Wall Street estimates. The company also revealed a forecast of $18.4 billion in Covid-19 vaccine sales for 2021. Shares of the drugmaker pared earlier gains to close at $148.38, up about 2.5%.
    The Cambridge, Massachusetts-based company reported a loss of $0.69 a share on sales of $570.7 million, double the $0.34 a share on sales of $279.4 million that analysts polled by FactSet expected.
    In the same period last year, Moderna lost 37...
    Read more ...

     

  • Moderna climbs as 4th-quarter sales blow past expectations and 2021 forecasts surge

    Moderna climbs as 4th-quarter sales blow past expectations and 2021 forecasts surge

    1 month ago - By Business Insider

    Moderna's COVID-19 vaccine is one of two that have been authorized for emergency use to fight the pandemic across the US. The other vaccine available is from Pfizer.
    Radek Mica /AFP via Getty Images
    Shares of Moderna soared as high as 10% on Thursday after it revealed fourth-quarter sales more than double Wall Street estimates.
    The company also revealed a forecast of $18.4 billion in Covid-19 vaccine sales for 2021.
    Moderna reported a loss of $0.69 a share on sales of $570.7 million, double the $.034 a share on sales of $279.4 million that analysts expected.
    Sign up here for our daily...
    Read more ...